Genetically engineered cardiac pacemaker: Stem cells transfected with HCN2 gene and myocytes - A model

被引:1
|
作者
Kanani, S. [1 ,2 ,5 ]
Pumir, A. [1 ,3 ,4 ,5 ]
Krinsky, V. [1 ,5 ]
机构
[1] CNRS, Inst Non Linear Nice, F-06560 Valbonne, France
[2] Inst Genom Fonct, F-34396 Montpellier, France
[3] Univ Nice, F-06108 Nice, France
[4] CNRS, Lab JA Dieudonne, F-06108 Nice, France
[5] Univ Nice, F-06560 Valbonne, France
关键词
biological pacemaker; gene therapy; oscillation; ion channels; stem cells;
D O I
10.1016/j.physleta.2007.07.075
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
One of the successfully tested methods to design genetically engineered cardiac pacemaker cells consists in transfecting a human mesenchymal stem cell (hMSC) with a HCN2 gene and connecting it to a myocyte. We develop and study a mathematical model, describing a myocyte connected to a hMSC transfected with a HCN2 gene. The cardiac action potential is described both with the simple Beeler-Reuter model, as well as with the elaborate dynamic Luo-Rudy model. The HCN2 channel is described by fitting electrophysiological records, in the spirit of Hodgkin-Huxley. The model shows that oscillations can occur in a pair myocyte-stem cell, that was not observed in the experiments yet. The model predicted that: (1) HCN pacemaker channels can induce oscillations only if the number of expressed IK1 channels is low enough. At too high an expression level of IK1 channels, oscillations cannot be induced, no matter how many pacemaker channels are expressed. (2) At low expression levels of IK1 channels, a large domain of values in the parameter space (n, N) exists, where oscillations should be observed. We denote N the number of expressed pacemaker channels in the stem cell, and n the number of gap junction channels coupling the stem cell and the myocyte. (3) The expression levels of IK1 channels observed in ventricular myocytes, both in the Beeler-Reuter and in the dynamic Luo-Rudy models are too high to allow to observe oscillations. With expression levels below similar to 4/4 of the original value, oscillations can be observed. The main consequence of this work is that in order to obtain oscillations in an experiment with a myocyte-stem cell pair, increasing the values of n, N is unlikely to be helpful, unless the expression level Of IK1 has been reduced enough. The model also allows us to explore levels of gene expression not yet achieved in experiments, and could be useful to plan new experiments, aimed at improving the robustness of the oscillations. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [41] Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma model
    Gu, Chunyu
    Li, Shaoyi
    Tokuyama, Tsutomu
    Yokota, Naoki
    Namba, Hiroki
    CANCER LETTERS, 2010, 291 (02) : 256 - 262
  • [42] Pacemaker activity and excitation spread in Cx43(-/-) cardiac myocytes derived from embryonic stem (ES) cells
    Banach, K
    Hescheler, E
    Egert, U
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 97A - 98A
  • [43] THERAPEUTIC EFFECT OF GENETICALLY ENGINEERED MESENCHYMAL STEM CELLS IN RAT EXPERIMENTAL LEPTOMENINGEAL GLIOMA MODEL
    Namba, Hiroki
    Gu, Chunyu
    Li, Shaoyi
    Tokuyama, Tsutomu
    Yokota, Naoki
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1059 - 1060
  • [44] THERAPEUTIC EFFECT OF GENETICALLY ENGINEERED MESENCHYMAL STEM CELLS IN RAT EXPERIMENTAL LEPTOMENINGEAL GLIOMA MODEL
    Gu, Chunyu
    Li, Shaoyi
    Yokota, Naoki
    Namba, Hiroki
    NEURO-ONCOLOGY, 2009, 11 (06) : 917 - 917
  • [45] Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy
    Amano, Shinji
    Li, Shaoyi
    Gu, Chunyu
    Gao, Yun
    Koizumi, Shinichiro
    Yamamoto, Seiji
    Terakawa, Susumu
    Namba, Hiroki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (06) : 1265 - 1270
  • [46] Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells
    Li, SY
    Tokuyama, T
    Yamamoto, J
    Koide, M
    Yokota, N
    Namba, H
    CANCER GENE THERAPY, 2005, 12 (07) : 600 - 607
  • [47] Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells
    Shaoyi Li
    Tsutomu Tokuyama
    Junkoh Yamamoto
    Masayo Koide
    Naoki Yokota
    Hiroki Namba
    Cancer Gene Therapy, 2005, 12 : 600 - 607
  • [48] Construction of liver model with genetically engineered human HEPG2 cells
    Omasa, T
    Enosawa, S
    ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 13, 2003, : 25 - 29
  • [49] Nanoparticle-enhanced generation of gene-transfected mesenchymal stem cells for in vivo cardiac repair
    Zhu, Kai
    Wu, Meiying
    Lai, Hao
    Guo, Changfa
    Li, Jun
    Wang, Yulin
    Chen, Yu
    Wang, Chunsheng
    Shi, Jianlin
    BIOMATERIALS, 2016, 74 : 188 - 199
  • [50] Downregulated lncRNA RCPCD promotes differentiation of embryonic stem cells into cardiac pacemaker-like cells by suppressing HCN4 promoter methylation
    Ye Zhu
    Jia You
    Wei Wei
    Jianjun Gu
    Chao Xu
    Xiang Gu
    Cell Death & Disease, 12